IPO Expert Panel Declares Prime Window for IPOs May be Poised to Gain Momentum

  IPO Expert Panel Declares Prime Window for IPOs May be Poised to Gain
  Momentum

LaVoie Group, SunTrust Robinson Humphrey and Mintz Levin Host IPO Preparedness
       Panel Discussion for Life Science, Emerging Growth Company CEOs

Business Wire

BOSTON & CAMBRIDGE, Mass. -- September 18, 2013

An expert life science industry panel with representation from banking, legal
and strategic communications yesterday discussed a historic snapshot of life
science initial public offering windows, declaring that the current financing
cycle for life science initial public offerings (IPOs) could be at the
half-way point, with a measurable increase in IPO activity in the coming
months. Yesterday’s IPO Preparedness Panel for Senior Management and Board
Members of Emerging Growth Companies event was hosted by LaVoie Group, a
strategic communications firm focused on the health & life sciences market, in
conjunction with SunTrust Robinson Humphrey and Mintz Levin.

Considering the recent surge of IPOs in the United States for life science and
med-tech companies, the panel was well attended, with many invitees noting the
relevance to their respective organizations. The panel reviewed key issues
that company leaders should consider before commencing the process of going
public. The panelists explored opportunities, planning parameters and risks
for senior management and board members considering a public company pathway.

The panel was led by three key opinion leaders with varied backgrounds,
offering a well-rounded discussion of the IPO process: Christine Gallagher,
Managing Director, Equity Capital Markets at SunTrust Robinson Humphrey, Megan
Gates, Member of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC., and Donna
LaVoie, Founder and CEO, LaVoie Strategic Communications Group (LaVoie Group).

Based on data presented by SunTrust Robinson Humphrey, Gallagher said, “Over
the last fifteen years, there have been four substantial life science IPO
windows before this one, lasting from 6-20 months with an average of 12
months. March 2013 kicked off the current window, indicating that this window
may have substantial additional prime opportunity for issuance.” Gallagher
added that she considers IPO “windows of strength” to be periods characterized
by six months or more of above average issuance with a relative absence of IPO
withdrawals and postponements. “Although we have seen these conditions since
March, issuance windows tend to gain momentum as the timeframe progresses,
indicating the most active portion of the current window may be yet to come,”
she said.

Gates addressed the complex process for filing with the Securities and
Exchange Commission to take a company public. “Preparing for an IPO generally
takes 12-18 months before a filing. The better prepared a company is going in
to the process, in terms of the business section, financial statements, board
and committee structure and other elements, the quicker and more smoothly the
process will run.”

LaVoie added, “It takes a partnership with both internal and external
resources to establish a company’s positioning and to identify appropriate and
attainable milestones. Building key relationships—well in advance— with the
right investors, analysts and media to tell your company’s story and to build
trust and transparency is critical path to a successful IPO and aftermarket
success.”

About LaVoie Group

LaVoie Group partners with leading life sciences brands to build value for
their companies, attract capital, and reach key stakeholders through
integrated communications and marketing. The firm provides strategy consulting
and integrated communications programs designed to properly position, create
visibility and drive value. The agency has received 18 awards in four years in
recognition of the work it has done for its clients.

Clients are emerging and established industry leaders in life sciences and
pharmaceuticals and governments, including but not limited to, Radius Health,
DARA Biosciences, BIO, Nuron Biotech, Haemonetics Corporation, Rockwell
Medical, the Commonwealth of Massachusetts, to-BBB, MorphoChem AG, RedSky
Partners and Xcovery Group of companies. LaVoie Group is ranked by O'Dwyer's
PR Report as one of the leading independent healthcare PR firms in the U.S.
and has been honored for the past four years by the LACP for best agency
awards, including the 2011 "Best Small Agency".

About SunTrust Robinson Humphrey

SunTrust Robinson Humphrey is the full-service corporate and investment
banking arm of SunTrust Banks, Inc. and is headquartered in Atlanta, Georgia.
It provides comprehensive capital raising, strategic advisory, risk
management, and investment solutions to serve the needs of corporate clients
across the nation. It also offers fixed income and equity research, sales and
trading for institutional investors.

SunTrust Robinson Humphrey has extensive experience working with public and
private companies of all sizes – from emerging growth to the Fortune 500.
While the company offers a complete array of solutions and advice for
companies across all industries, it provides in-depth industry expertise and
dedicated corporate and investment banking practices for certain core sectors,
including business services, financial sponsors, building products,
healthcare, consumer and retail, media and communications, energy,
transportation, and financial services and technology.

More information on SunTrust Robinson Humphrey can be found at
www.suntrustrh.com.

About Mintz Levin

Mintz Levin, a full-service law firm comprised of 450 attorneys with eight
offices (Boston, New York, San Diego, San Francisco, Washington, Stamford, Los
Angeles, and London) and an affiliate relationship in Israel, has served as
one of the leading law firms to the life sciences industry since the
industry’s birth in the 1970s. Today, the firm advises hundreds of businesses
and other organizations in all sectors of the industry’s ecosystem -- from
start-ups looking for their first funding to public companies with products on
the market, as well as venture capital firms, investment banks, and research
and academic institutions. Our attorneys provide experienced counsel to
clients globally in a broad range of matters, including corporate finance and
securities, mergers and acquisitions, licensing and collaborations,
intellectual property, litigation, regulatory, employment and benefits,
bankruptcy and commercial lending, immigration, and real estate.

Contact:

For LaVoie Group
Donna LaVoie, 617-374-8800
dlavoie@lavoiegroup.com
or
Christine Gallagher
christine.gallagher@suntrust.com
or
Megan Gates
mgates@mintz.com
 
Press spacebar to pause and continue. Press esc to stop.